F-group (family)
5.1.4.14 Peptidase_S9_N
Ligands and drugs
184
Member domains
94
with ligand contacts (≤ 4 Å)
51.1% of members
66
with DrugDomain annotations
35.9% of members
59
with a DrugBank compound
32.1% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5.1.4.14 belongs to X-group 5 beta-propeller-like, which binds 7.8 ligand superclasses per 20 proteins, broader than 52% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03535 | ZPR | Z-Pro-Prolinal | 11 |
| DB00127 | SPM | Spermine | 5 |
| DB00139 | SIN | Succinic acid | 3 |
| DB00145 | GLY | Glycine | 3 |
| DB04033 | ZAH | Z-Ala Prolinal | 2 |
| DB08603 | TCK | N-[(1S)-5-amino-1-(chloroacetyl)pentyl]-4-methylbenzenesulfonamide | 2 |
| DB01684 | SGL | 1-Hydroxy-1-Thio-Glycerol | 1 |
| DB02159 | PGR | (R)-Propylene glycol | 1 |
| DB07148 | 552 | (6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one | 1 |
| DB08738 | X98 | 1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one | 1 |
| DB08739 | X99 | 2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZPR | N-BENZYLOXYCARBONYL-L-PROLYL-L-PROLINAL | 18 |
| NAmetal | SODIUM ION | 10 |
| SPM | SPERMINE | 8 |
| CAmetal | CALCIUM ION | 5 |
| MGmetal | MAGNESIUM ION | 4 |
| SIN | SUCCINIC ACID | 3 |
| CL | CHLORIDE ION | 2 |
| NImetal | NICKEL (II) ION | 2 |
| ZAH | N-[(BENZYLOXY)CARBONYL]-L-ALANYL-L-PROLINE | 2 |
| 15P | POLYETHYLENE GLYCOL (N=34) | 1 |
| 2P2 | 1-[(2R,5S)-2-tert-butyl-5-({(2S)-2-[(1R)-1,2-dihydroxyethyl]pyrrolidin-1-yl}carbonyl)pyrrolidin-1-yl]-4-phenylbutan-1-one | 1 |
| 2P4 | (5R)-N-benzyl-5-({(2S)-2-[(1R)-1,2-dihydroxyethyl]pyrrolidin-1-yl}carbonyl)cyclopent-1-ene-1-carboxamide | 1 |
| 2P6 | (2S)-1-[1-(4-phenylbutanoyl)-L-prolyl]pyrrolidine-2-carbonitrile | 1 |
| 2P8 | (2S)-N-benzyl-2-({(2S)-2-[(1R)-1,2-dihydroxyethyl]pyrrolidin-1-yl}carbonyl)pyrrolidine-1-carboxamide | 1 |
| 4I4 | (5R,6R,8S)-8-(3-{[AMINO(IMINO)METHYL]AMINO}PHENYL)-5-CYCLOHEXYL-6-HYDROXY-3-OXO-1-PHENYL-2,7-DIOXA-4-AZA-6-PHOSPHANONAN-9-OIC ACID 6-OXIDE | 1 |
| 552 | (6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one | 1 |
| B3P | 2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL | 1 |
| BKO | 1-[4-oxidanyl-2-(1,3-thiazolidin-3-ylcarbonyl)pyrrolidin-1-yl]-4-[2-[(~{E})-2-phenylethenyl]phenoxy]butan-1-one | 1 |
| JKT | tert-butyl N-[[1-[(3S,5S)-5-[(2S)-2-[azanyl(oxidanyl)methyl]pyrrolidin-1-yl]carbonyl-1-(4-phenylbutanoyl)pyrrolidin-3-yl]-1,2,3-triazol-4-yl]methyl]carbamate | 1 |
| P0H | N-[(benzyloxy)carbonyl]glycyl-L-proline | 1 |